miR-134-5p Promotes Stage I Lung Adenocarcinoma Metastasis and Chemoresistance by Targeting DAB2

Despite surgery and adjuvant therapy, early-stage lung adenocarcinoma (LUAD) treatment often fails due to local or metastatic recurrence. However, the mechanism is largely unknown. Here, we report that increased expression levels of miR-134-5p and decreased levels of disabled-2 (DAB2) were significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liang, Huang, Ping, Li, Qing, Wang, Dong, Xu, Cheng-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838973/
https://www.ncbi.nlm.nih.gov/pubmed/31689617
http://dx.doi.org/10.1016/j.omtn.2019.09.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838973/
https://www.ncbi.nlm.nih.gov/pubmed/31689617
http://dx.doi.org/10.1016/j.omtn.2019.09.025

Ejemplares similares